The Food Safety and Standards Authority of India (FSSAI) has launched a surveillance drive to tackle the production of spurious drugs by nutraceutical companies in India. The initiative began with inspections in Himachal Pradesh, specifically in Baddi, where 21 facilities were inspected and 111 samples were lifted between June 7 and June 9, 2023. The FSSAI plans to inspect 25–30% of nutraceutical manufacturing facilities in Himachal Pradesh by the end of June 2023.
In order to address the issue of spurious drugs, the CEO of FSSAI held a meeting with major manufacturers of health supplements and nutraceuticals in Baddi, Himachal Pradesh, on June 20, 2023. During the meeting, the CEO issued a strong warning about the importance of strict compliance with nutraceutical regulations. Non-compliance could result in license suspension or cancellation, as well as the initiation of criminal cases.
To ensure a coordinated effort, the FSSAI has directed the Commissioner of Food Safety in Himachal Pradesh to provide full support for the surveillance drive. Food Business Operators (FBOs) found to be in violation may be prosecuted under Section 59 of the FSS Act, 2006, which carries severe penalties, including life imprisonment or a fine of not less than Rs. 10 lakhs.
To encourage citizen involvement in maintaining food safety, the FSSAI has introduced the Food Safety Connect app, a consumer grievance portal available on iOS and Android platforms. This user-friendly platform allows individuals to promptly report any non-compliance or violations they encounter. By utilizing this app, the FSSAI can take swift action and effectively address reported issues.